Skip to main content
Cancer Research Communications logoLink to Cancer Research Communications
. 2022 Dec 19;2(12):1668. doi: 10.1158/2767-9764.CRC-22-0510

Correction: A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice

Natalia E Cortez, Cecilia Rodriguez Lanzi, Brian V Hong, Jihao Xu, Fangyi Wang, Shuai Chen, Jon J Ramsey, Matthew G Pontifex, Michael Müller, David Vauzour, Payam Vahmani, Chang-il Hwang, Karen Matsukuma, Gerardo G Mackenzie
PMCID: PMC10035528  PMID: 36970724

In the original version of this article (1), there is an error in the abstract. The macronutrient composition of both the ketogenic and control mouse diets was incorrectly reported in the abstract. The Materials and Methods section included the correct compositions and remains unchanged. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Reference

  • 1. Cortez NE, Lanzi CR, Hong BV, Xu J, Wang F, Chen S, et al. A ketogenic diet in combination with gemcitabine increases survival in pancreatic cancer KPC mice. Cancer Res Commun 2022;2:951–65. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Research Communications are provided here courtesy of American Association for Cancer Research

RESOURCES